Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target ...

Ozempic may affect your face, bowel movements and hair. Check out the Ozempic side effects before taking this anti-diabetes ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

This health crisis is largely attributed to sedentary lifestyles, excessive consumption of processed and fast food, and ...

Doctors are also seeing success in treating people with certain liver diseases. Isaacs prescribes GLP-1s for people with a ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

The ability to not just halt but potentially reverse this scarring process could transform how we approach advanced liver disease treatment. Participants receiving semaglutide experienced an ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to read my most recent analysis.

The study targets adults in China with overweight or obesity accompanied metabolic dysfunction-associated fatty liver disease (MAFLD ... of mazdutide versus semaglutide in Chinese adults with ...

The latest Chinese guidelines recommended GLP-1 agents such as semaglutide ... and provide a better treatment option for Chinese patients with overweight or obesity accompanied MAFLD." MAFLD is the ...